Myths vs facts: AMH and blood sugar

The question of myths vs facts regarding AMH (Anti-Müllerian hormone) and blood sugar is nuanced, as the provided context contains no direct information on this topic. AMH is primarily a marker of ovarian reserve, not glucose metabolism. Some research suggests a link between AMH and insulin resistance, especially in women with polycystic ovary syndrome (PCOS), where elevated AMH may correlate with impaired glucose tolerance. However, the evidence is moderate and insufficient to establish AMH as a clinical blood sugar marker. No validated guidelines recommend AMH for diabetes diagnosis or monitoring. Myths claiming AMH predicts blood sugar spikes or diabetes risk are overstated. Actual blood sugar control should rely on fasting glucose, HbA1c, and oral glucose tolerance tests. An AMH test alone cannot replace these measurements. Caution is warranted when interpreting direct-to-consumer tests that imply such connections. The evidence is rated as 'unclear' due to lack of context support.